Founding Management

Mark J. Burk, PhD

President & CEO

A serial entrepreneur, Mark has over 30 years of experience in academia and biotech/pharma at both small and large companies. He has built high performance teams, new technologies, platforms, IP portfolios, and product pipelines, from ideation to commercialization.   Mark  earned a Ph.D. in organic chemistry from Yale University and performed postdoctoral work at MIT with Nobel laureate Barry Sharpless.  Mark has published over 80 peer-reviewed papers and is an inventor on over 300 patents.  Mark has received many honors and awards and has presented over 300 lectures at major conferences and universities.  For more information, see:  https://www.linkedin.com/in/mark-burk-5a345330/

Kent S. Boles, PhD

Head of R&D

Kent is a full stack synthetic biologist and immunologist with over 20 years of experience in automation and DNA workflows. As a postdoctoral researcher at University of Oxford and Washington University,  he discovered several immuno-oncology targets and later established a phage display core targeting nanoparticles with peptides. Kent was also the technical lead for the Digital to Biological Converter at Synthetic Genomics, the world’s first fully automated platform to produce biologic compounds from digital DNA designs. The device brought together synthetic biology workflows with bioinformatics and engineering disciplines. https://www.linkedin.com/in/kentboles/

Academic Founders

Prof. Douglas Mitchell, PhD


World Expert - Lasso peptides

Prof. Tracy Handel, PhD


World Expert - GPCRs, chemokine receptors

© 2020 by Lassogen, Inc.

  • Black Twitter Icon
  • Black LinkedIn Icon